Ketamine IV Classic Protocol : Five Years Follow up

NCT ID: NCT04824157

Last Updated: 2021-04-01

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 11 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2019-08-08
• Study Completion Date: 2020-03-30

Brief Summary

Patients who suffer from MDD recieved ketamnie (2014-15) in open study will be addressed and there depression mood will be evaluated using the rating scale that were used in the original research. In addition time of relapse and questions about their medications and drug use will be performed.

Detailed Description

Patients who suffer from Major Depressive disorder and are outpatients in our clinic and, received in the years (2014-15) ketamine in open study will be addressed and there depression mood will be evaluated using the rating scale that were used in the original research. In addition time of relapse and questions about their medications and drug use will be performed.

Conditions

Major Depressive Disorder; Drug Abuse; Medications; Relapse

Study Design

• Observational Model Type: OTHER
• Study Time Perspective: RETROSPECTIVE

Interventions

Non

Follow up

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Patient who participated in ketamine study 1126

Exclusion Criteria

• None

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 80 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Sheba Medical Center

OTHER_GOV

Sponsor Role: lead

Responsible Party

Dr. Revital Amiaz

Head of Department Psychiatry B

Responsibility Role: PRINCIPAL_INVESTIGATOR

Locations

The Chaim Sheba Medical Center

Tel Litwinsky, , Israel

Countries

Israel

Other Identifiers

5826-18-SMC

Identifier Type: -

Identifier Source: org_study_id